Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995758 · ClinicalTrials.gov registry record · NA
MOSES Lithotripsy Technology Applied to Stone Fragmentation During Ureteroscopy
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT03995758 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 116 participants.
The verdict
NCT03995758, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
To determine if the effects of MOSES laser modulation technology can improve the safety and efficiency to laser fragmentation resulting in decreased total laser time, reduced potential for injury to the patient, and total OR time and utilization.
Interventions
- DEVICE MOSES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03995758
The ClinicalTrials.gov registry entry for NCT03995758 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MOSES is the first listed.
NCT03995758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03995758 about?
NCT03995758 is a clinical study titled "MOSES Lithotripsy Technology Applied to Stone Fragmentation During Ureteroscopy". To determine if the effects of MOSES laser modulation technology can improve the safety and efficiency to laser fragmentation resulting in decreased total laser time, reduced potential for injury to the patient, and total OR time and utilization.
What is the current status of trial NCT03995758?
This trial is currently terminated. It is a NA study. The enrollment target is 116 participants. The study started on 2019-06-06. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT03995758?
The interventions under investigation include: MOSES (DEVICE).
Who is sponsoring clinical trial NCT03995758?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.